SILO ▼ -3.0% - Silo Pharma, Inc. $SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum Silo Pharma shares fell 3.0% today despite the company announcing plans to showcase its proprietary nasal drug delivery technology for PTSD treatment at the 2026 Nasal Innovation Forum. The decline suggests investors may have been disappointed by the timing of the presentation or lacked concrete clinical or commercial updates to drive near-term enthusiasm. 09-SEP-2026 09:15 AM ET